← Back to Search

Cognitive Behavioral Therapy for COPD and Emotional Distress

N/A
Recruiting
Led By Patricia Bamonti, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Competent to provide informed consent
Clinical diagnosis of COPD defined as either the ratio of FEV1 to forced vital capacity < 0.70 or prior documentation of FEV1/FVC ratio of < 0.70 and clinical evidence of COPD (defined as > 10 pack-year cigarette smoking history, dyspnea, or on bronchodilators)
Must not have
Use of assistive device for walking such as cane or walker
Prescribed supplemental oxygen for activity
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 8 (mid-point), week 16 (post-intervention)- measuring change
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a new physical and mental health intervention for Veterans with COPD, emotional distress, and low physical activity. The intervention will be delivered via VA Video Connect.

Who is the study for?
Veterans over 40 with COPD, experiencing depression or anxiety, and not meeting physical activity guidelines. They must have internet access, be able to attend VA sessions, communicate in English, consent to audio recording and wear a Fitbit. Excluded are those highly active or engaged in other exercise studies, needing walking aids or oxygen for activity.
What is being tested?
The trial is developing an integrated intervention combining physical activity and mental health support for veterans with COPD who also suffer from emotional distress. Delivered via video connect, it aims to improve both COPD outcomes and mental well-being.
What are the potential side effects?
As this is a non-drug intervention focusing on physical activity and cognitive-behavioral therapy (Step-CBT), typical medication side effects are not expected. However, participants may experience discomfort related to increased physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I understand and can agree to the study's procedures and risks.
Select...
I have been diagnosed with COPD and have a history of significant smoking.
Select...
I am 40 years old or older.
Select...
I have significant depression or anxiety.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I use a cane or walker to help me walk.
Select...
I need extra oxygen when I move around.
Select...
I have had a worsening of my COPD in the last month.
Select...
I cannot walk, even with help.
Select...
I am currently seeing a therapist for mental health support.
Select...
I can stand up from a chair in less than 16.7 seconds.
Select...
I couldn't track my steps for at least 8 days in the last two weeks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 8 (mid-point), week 16 (post-intervention)- measuring change
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 8 (mid-point), week 16 (post-intervention)- measuring change for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Measuring change - Late Life Function and Disability Instrument (LLFDI)
Step Count-measuring change
Secondary study objectives
Anxiety
Exercise Capacity
Patient Health Questionniare-8- measuring change

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Step-CBTExperimental Treatment1 Intervention
Participants will complete Step-CBT, an integrative 8-week physical activity and cognitive behavioral therapy (CBT) intervention, delivered by a licensed clinical psychologist. Sessions will take place once per week for 60 minutes using VA Video Connect. Each session will include core components 1) Reviewing physical activity goals, prescribing new step count goal, and problem-solving barriers and 2) The weekly CBT intervention module.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,666 Previous Clinical Trials
3,765,784 Total Patients Enrolled
Patricia Bamonti, PhDPrincipal InvestigatorVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Media Library

Step-CBT Clinical Trial Eligibility Overview. Trial Name: NCT04953806 — N/A
Chronic Obstructive Pulmonary Disease Research Study Groups: Step-CBT
Chronic Obstructive Pulmonary Disease Clinical Trial 2023: Step-CBT Highlights & Side Effects. Trial Name: NCT04953806 — N/A
Step-CBT 2023 Treatment Timeline for Medical Study. Trial Name: NCT04953806 — N/A
~9 spots leftby Nov 2026